Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rubio-Terrés

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Actas Espanolas De Psiquiatria|June 1, 2006
[Cost-effectiveness of venlafaxine for the treatment of depression and anxiety. Bibliographic review]E Baca Baldomero, C Rubio-Terrés
Revista De Neurologia|June 24, 2005
[Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain]C Rubio-Terrés, A Domínguez-Gil Hurlé
Revista Clinica Espanola|February 1, 1990
[Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease]C Rubio Terrés, M López Alvarez, E Vargas Castrillón
Actas Espanolas De Psiquiatria|June 27, 2007
Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the longitudinal study Ziprasidone Extended Use in Schizophrenia (ZEUS)M Bernardo, J R Azanza, C Rubio-Terrés, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 29, 2009
Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort studyC Rubio-Terrés, J Garau, S Grau, et al.
Pharmacoeconomics|May 27, 1999
Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in SpainF J Jiménez, P Guallar-Castillón, C Rubio Terrés, et al.
Anales Espanoles De Pediatria|March 14, 1998
[Review of the data on incidence of invasive disease and meningitis caused by Haemophilus influenzae in children under 5 years of age in Spain]P Guallar-Castillón, F J Jiménez, C Rubio Terrés, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 2, 2003
[Cost-utility analisys of multiple sclerosis treatment with glatiramer acetate or interferon beta in Spain]C Rubio-Terrés, I Arístegui Ruiz, F Medina Redondo, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 2005
Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in SpainS Grau, F Alvarez-Lerma, A del Castillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 9, 2006
Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancerJ M Gil, C Rubio-Terrés, A Del Castillo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Actas Espanolas De Psiquiatria|June 1, 2006
[Cost-effectiveness of venlafaxine for the treatment of depression and anxiety. Bibliographic review]E Baca Baldomero, C Rubio-Terrés
Revista De Neurologia|June 24, 2005
[Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain]C Rubio-Terrés, A Domínguez-Gil Hurlé
Revista Clinica Espanola|February 1, 1990
[Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease]C Rubio Terrés, M López Alvarez, E Vargas Castrillón
Actas Espanolas De Psiquiatria|June 27, 2007
Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the longitudinal study Ziprasidone Extended Use in Schizophrenia (ZEUS)M Bernardo, J R Azanza, C Rubio-Terrés, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 29, 2009
Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort studyC Rubio-Terrés, J Garau, S Grau, et al.
Pharmacoeconomics|May 27, 1999
Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in SpainF J Jiménez, P Guallar-Castillón, C Rubio Terrés, et al.
Anales Espanoles De Pediatria|March 14, 1998
[Review of the data on incidence of invasive disease and meningitis caused by Haemophilus influenzae in children under 5 years of age in Spain]P Guallar-Castillón, F J Jiménez, C Rubio Terrés, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 2, 2003
[Cost-utility analisys of multiple sclerosis treatment with glatiramer acetate or interferon beta in Spain]C Rubio-Terrés, I Arístegui Ruiz, F Medina Redondo, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 2005
Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in SpainS Grau, F Alvarez-Lerma, A del Castillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 9, 2006
Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancerJ M Gil, C Rubio-Terrés, A Del Castillo, et al.
Pageof 3